Your browser doesn't support javascript.
loading
Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay.
de Miranda Silva, Carolina; Hajihosseini, Amirhossein; Myrick, Jenny; Nole, Jocelyn; Louie, Arnold; Schmidt, Stephan; Drusano, George L.
Afiliación
  • de Miranda Silva C; Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Hajihosseini A; Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Myrick J; Institute for Therapeutic Innovation, College of Medicine, University of Florida, Orlando, Florida, USA.
  • Nole J; Institute for Therapeutic Innovation, College of Medicine, University of Florida, Orlando, Florida, USA.
  • Louie A; Institute for Therapeutic Innovation, College of Medicine, University of Florida, Orlando, Florida, USA.
  • Schmidt S; Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA sschmidt@cop.ufl.edu.
  • Drusano GL; Institute for Therapeutic Innovation, College of Medicine, University of Florida, Orlando, Florida, USA.
Antimicrob Agents Chemother ; 63(1)2019 01.
Article en En | MEDLINE | ID: mdl-30397058
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Modelos Estadísticos / Moxifloxacino / Mycobacterium tuberculosis / Nitroimidazoles / Antituberculosos Tipo de estudio: Risk_factors_studies Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Modelos Estadísticos / Moxifloxacino / Mycobacterium tuberculosis / Nitroimidazoles / Antituberculosos Tipo de estudio: Risk_factors_studies Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos